课题基金 / 基金详情

The basic and clinical study for the personalized oral cancer therapy

The basic and clinical study for the personalized oral cancer therapy
口腔癌个性化治疗的基础与临床研究
批准号:
19390523
负责人:
FUKUDA Masakatsu
金额:
$10.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2007
资助国家:
日本
项目状态:
已结题
起止时间:
2007 至 2009

项目摘要

项目成果

FUKUDA Masakatsu的其他基金

相似基金

相关文献

中文摘要
翻译
口腔鳞状细胞癌是口腔最常见的恶性肿瘤,P53抑癌基因的频繁改变与口腔鳞状细胞癌的发生发展密切相关,尤其是30%~50%的口腔鳞状细胞癌。P33^lt;ING1b>与P53的关系密切,P53和p33^lt;ING1b>单独都不能引起细胞生长抑制,这促使我们研究它们在口腔癌发生中的潜在作用。此外,核因子-κB(NF-κB)在炎症、免疫反应、肿瘤发生和抗细胞凋亡等方面发挥着重要作用。最近有报道称,NF-κB的功能受P53的调节。在本研究中,我们研究了p33^<ING1b>过表达对紫杉醇诱导的HOSCC细胞凋亡和caspase激活的影响,以确定p33^<ING1b>异构体是否在HOSCC的化疗敏感性中起作用。以往的实验证据表明,p33^<ING1b>在控制细胞生长、衰老和凋亡方面与p53在功能上具有协同作用。在紫杉醇诱导的HOSCC细胞凋亡中,p33^lt;ING1b>可能与P53协同作用。为了验证这一假说,我们利用含有野生型和突变型P53的HOSCC细胞株,研究了p33^<ING1b>过表达对细胞凋亡的促进作用及其机制。我们发现外源p33^<ING1b>在野生型p53细胞中的过表达可以显著促进紫杉醇诱导的细胞凋亡。
英文摘要
Human oral squamous cell carcinoma (HOSCC) is the most common malignant tumor in the oral cavity, and that frequent alteration of p53 tumor suppressor gene is associated with the development of HOSCC, especially in 30% to 50% of that. The p33^<ING1b> has a close relationship with p53 and that neither p53 nor p33^<ING1b> alone can cause cell growth inhibition, which prompted us to investigate their potential role in oral carcinogenesis. Furthermore, Nuclear factor-κB (NF-κB) has key roles in inflammation, immune response, tumorigenesis and protection against apoptosis. It has recently been reported that the function of NF-κB is regulated by p53. In this study, to determine whether the p33^<ING1b> isoform plays a role in chemosentivity of HOSCC, we investigated the effect of p33^<ING1b> overexpression on taxol-induced apoptosis and the activation of caspases in HOSCC cells. Previous experimental evidences indicated that p33^<ING1b> functionally cooperates with p53 in controlling cell growth, senescence and apoptosis. The p33^<ING1b> may cooperate with p53 in taxol-induced apoptosis of the HOSCC. To test this hypothesis, the HOSCC cell lines, contained wild-type p53 and mutant p53, were employed to examine the enhancement ofapoptosis by p33^<ING1b> overexpression and its mechanism. We found that overexpression of exogenous p33^<ING1b> in wild-type p53 cell line can dramatically promote taxol-induced apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CYLD regulates NF-κB and its related factors expression in salivary gland tumors
CYLD调节唾液腺肿瘤中NF-κB及其相关因子的表达
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [福田正勝, 中野みゆき, 鈴木正二, 草間薫, 坂下英明, Masakatsu Fukuda, 福田正勝, Masakatsu Fukuda, Masakatsu Fukuda]
通讯作者: Masakatsu Fukuda
DOI: 10.3892/ijo_00000620
发表时间: 2010-06-01
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY
影响因子: 5.2
作者: [Fukuda, Masakatsu, Ehara, Masahiro, Sakashita, Hideaki]
通讯作者: Sakashita, Hideaki
Interleukin-23 and its receptors expression in human squamous cell carcinoma of the oral cavity.
Interleukin-23 及其受体在人口腔鳞状细胞癌中的表达。
DOI: --
发表时间: 2010
期刊: Molecular Medicine Reports 3
影响因子: --
作者: [Masakatsu Fukuda, Masahiro Ehara, Seiji Suzuki, Hideaki Sakashita]
通讯作者: Hideaki Sakashita
CYLDは唾液腺腫瘍におけるNF-κBとその関連因子の発現を調節する
CYLD调控唾液腺肿瘤中NF-κB及其相关因子的表达
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [福田正勝, 奥結香, 鈴木正二, 草間薫, 坂下英明]
通讯作者: 坂下英明
共 16 条
    The development of effective therapy by the inhibition of cell proliferation and invasion in oral cancer
    • 批准号:
      16390598
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.42万
    • 财政年份:
      2004
    • 负责人:
      FUKUDA Masakatsu
    • 依托单位:
    The role of neuropeptides on ocular physiology and pathophysiology
    • 批准号:
      60480389
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $2.94万
    • 财政年份:
      1985
    • 负责人:
      FUKUDA Masakatsu
    • 依托单位:
    海外基金